ISRCTN75765780已完成不适用
Anti-TNF-alpha (Infliximab) in Complex Regional Pain Syndrome
Erasmus Medical Centre (Netherlands)0 个研究点目标入组 24 人开始时间: 2006年1月27日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Men and women between 18 and up until 65 years
- •2. Established diagnosis of CRPS-1 according to the Bruehl/Budapest criteria
- •3. Are considered eligible according to tuberculosis screening criteria
排除标准
- •1. Disease related reasons
- •2. Abnormal laboratory findings
- •3. Adverse co-medication (such as corticosteroids, non-steroidal anti-inflammatory drugs [NSAIDs])
- •4. In general: concomitant congestive heart failure, pregnancy, receiving other recombinant products, history of serious infections, HIV, hepatitis B or C, abnormal chest radiograph, history of lymphoproliferative disease, opportunistic infection (e.g. herpes zoster), presence of a transplanted solid organ, history of alcohol abuse
研究者
相似试验
已完成
2 期
Infliximab effectiveness in COVID-19 patientsIRCT20201229049873N1Shahre-kord University of Medical Sciences40
已完成
2 期
Efficacy, Safety, and Tolerability Study of Infliximab in Juvenile SpondyloarthropathiesSpondylarthropathiesNCT00591201Hospital General de Mexico26
已完成
不适用
Infliximab(anti human TNF alfa monoclonal antibody, Remicade) off-label treatment for refractory Kawasaki diseaseKawasaki diseaseJPRN-UMIN000007423Department of Pediatrics, Saitama Medical Center, Saitama Medical University5
已完成
3 期
A Study of the Safety and Efficacy of Infliximab in Patients With PsoriasisPsoriasisNCT00106834Centocor, Inc.378
已完成
2 期
Effect of Infliximab on treatment of cirrhosis.Cryptogenic cirrhosis.Other and unspecified cirrhosis of liverIRCT2016052228003N1Research center for infectious diseases of digestive system, research adjutancy of Ahvaz Jundishapur30